iCBT for GD and Comorbidities - a Pilot

Karolinska Institutet30 enrolled

Overview

The study is a pilot study (Total N=30), with at pre, weekly during treatment, post and at three-month follow-up.

Recruitment will be done through online advertisement via social media and gambling-related websites. Participants will self-referred to the study via a study dedicated website (www.spelstudien.se). Login to a treatment platform will be verified using double authentication (detailed description of the online platform is provided in the application to the Swedish Ethical Review Authority). Written information about the study will be provided on the web page. Consent will be done online, with the possibility for participants to download study information and consent. Consenting participants will start a screening procedure. After screening, participants will be contacted for a telephone assessment with a clinical psychologist. During this interview, participants will be assessed for GD with a diagnostic interview, as well as the inclusion criteria for utilization of "Spelpaus". If meeting criteria for the study, participants will be referred to the baseline/ pre-measures - which will start with an additional informed consent for the treatment phase and the iCBT. Inclusion will be done after the completion of the informed consent and baseline/pre-measures. After that, participant will get access to the iCBT.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Gambling Disorder Comorbidities and Coexisting Conditions

Interventions

iCBT for Gambling Disorder and psychiatric comorbiditiesBEHAVIORAL

The iCBT, is based on the gambling pathways model. As a clinical conceptualization, the treatment build on loss of control, but also include additional interventions (e.g., emotion regulation and impulse control) targeting the etiological co-morbidity factors in the pathways model for emotionally vulnerable and impulsive gamblers (pathways subtypes 2 and 3).

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Screen positive for GD, as measured with the Gambling Disorder Identification Test (total score ≥20 GDIT). * Fulfilling GD, assessed according to the Structured Clinical Interview for Gambling Disorder (SCI-GD). * Utilization of "Spelpaus" (3 months from treatment start). * ≥18 years of age. * Able to provide digital informed consent. * Classified within pathways 2 or 3, as measured with the Gambling pathways Questionnaire (GPQ). * Screen positive for at least one common mental diagnosis in addition to GD, assessed according to the Web Screening Questionnaire (WSQ). Exclusion Criteria: * Other ongoing psychological treatment for GD. * Severe depression, screened according to the Montgomery Åsberg Depression Rating Scale (total score \>34 MADRS-S). * Suicidality, screening of ≥4 points on item 9 of the MADRS-S

Locations (1)

Centre for psychiatry research

Stockholm, Sweden

RECRUITING

Outcomes

Primary Outcomes

The Gambling Symptom Assessment Scale

Primary outcome will be gambling symptoms, measured with the the Gambling Symptom Assessment Scale. Minimum score is 0 and maximum score is 48, with higher scores indicated higher frequency of gambling symptoms.